138 related articles for article (PubMed ID: 29545337)
1. RNA fusions involving
Vallois D; Dupuy A; Lemonnier F; Allen G; Missiaglia E; Fataccioli V; Ortonne N; Clavert A; Delarue R; Rousselet MC; Fabiani B; Llamas-Gutierrez F; Ogawa S; Thome M; Ko YH; Kataoka K; Gaulard P; de Leval L
Haematologica; 2018 Aug; 103(8):e360-e363. PubMed ID: 29545337
[No Abstract] [Full Text] [Related]
2. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
3. Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):e271. PubMed ID: 27252517
[No Abstract] [Full Text] [Related]
4. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
[TBL] [Abstract][Full Text] [Related]
5. Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Gong Q; Wang C; Rohr J; Feldman AL; Chan WC; McKeithan TW
Haematologica; 2016 Jun; 101(6):e269-70. PubMed ID: 27252516
[No Abstract] [Full Text] [Related]
6. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.
Rohr J; Guo S; Huo J; Bouska A; Lachel C; Li Y; Simone PD; Zhang W; Gong Q; Wang C; Cannon A; Heavican T; Mottok A; Hung S; Rosenwald A; Gascoyne R; Fu K; Greiner TC; Weisenburger DD; Vose JM; Staudt LM; Xiao W; Borgstahl GE; Davis S; Steidl C; McKeithan T; Iqbal J; Chan WC
Leukemia; 2016 May; 30(5):1062-70. PubMed ID: 26719098
[TBL] [Abstract][Full Text] [Related]
7. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T; Paterson JC; Ballabio E; Chott A; Natkunam Y; Rodriguez-Justo M; Plonquet A; Rodriguez-Pinilla SM; Klapper W; Hansmann ML; Pileri SA; Isaacson PG; Stein H; Piris MA; Mason DY; Gaulard P
Haematologica; 2010 Mar; 95(3):432-9. PubMed ID: 20207847
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.
Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L
Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 2q33genetic polymorphisms in Tunisian endemic pemphigus foliaceus.
Abida O; Bahloul E; Ben Jmaa M; Sellami K; Zouidi F; Fakhfakh R; Mahfoudh N; Turki H; Masmoudi H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1476. PubMed ID: 32875738
[TBL] [Abstract][Full Text] [Related]
11. T cells: A proliferation of costimulatory molecules.
Mueller DL
Curr Biol; 2000 Mar; 10(6):R227-30. PubMed ID: 10744968
[TBL] [Abstract][Full Text] [Related]
12. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
13. Follicular helper T-cell lymphoma: a B-cell-rich variant of T-cell lymphoma.
Ruiz SJ; Cotta CV
Ann Diagn Pathol; 2015 Aug; 19(4):187-92. PubMed ID: 25913305
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
15. Mice transgenic for human
Lee GJ; Jun Y; Jeon YK; Lee D; Lee S; Kim J
Oncoimmunology; 2022; 11(1):2015170. PubMed ID: 35003894
[No Abstract] [Full Text] [Related]
16. Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.
Gmyrek GB; Pingel J; Choi J; Green JM
Cell Immunol; 2017 Sep; 319():28-34. PubMed ID: 28711152
[TBL] [Abstract][Full Text] [Related]
17. Follicular variant of peripheral T cell lymphoma with mediastinal involvement in a child: a case report.
Delas A; Gaulard P; Plat G; Brousset P; Laurent C
Virchows Arch; 2015 Mar; 466(3):351-5. PubMed ID: 25604350
[TBL] [Abstract][Full Text] [Related]
18. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
Karabon L; Tupikowski K; Tomkiewicz A; Partyka A; Pawlak-Adamska E; Wojciechowski A; Kolodziej A; Dembowski J; Zdrojowy R; Frydecka I
Pathol Oncol Res; 2017 Oct; 23(4):837-843. PubMed ID: 28101800
[TBL] [Abstract][Full Text] [Related]
19. Immune regulation by novel costimulatory molecules.
Dong C; Nurieva RI; Prasad DV
Immunol Res; 2003; 28(1):39-48. PubMed ID: 12947223
[TBL] [Abstract][Full Text] [Related]
20. Follicular variant of peripheral T-cell lymphoma mimicking follicular lymphoma: a case report with a review of the Literature.
Goto N; Tsurumi H; Sawada M; Kanemura N; Hara T; Kasahara S; Kito Y; Takada K; Sato Y; Yoshino T; Moriwaki H; Takami T
Pathol Int; 2011 May; 61(5):326-30. PubMed ID: 21501301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
